Duvyzat acts as a histone deacetylase (HDAC) inhibitor; while its exact mechanism of action in treating DMD is still unclear, studies have revealed increased HDAC activity in these patients. The gene discussed is HDAC9; the disease is Duchenne muscular dystrophy.